Not for the feint of heart. They had a terrible year, but catalysts are coming, including an analysts' day in early October. There will be a decision on the merger with Grail. If the EU blocks it, Illumina will spin it out and that will be a big catalyst.
Consumer Products

Unlock the latest expert's opinion. Its free

Create a FREE account to see the latest opinions & get alerts about when to buy, sell or hold stocks

Unlock the latest opinion & get signals
(A Top Pick Jun 11/21, Down 58%) Company still growing in double digits. New M&A has yet to be recognized by market. Waiting to see whether there is valuation compression or whether fundamental problem with company. Will continue to hold shares in company.
Consumer Products
Stock price is priced low due to litigation problems & recent selloff in tech. Management has guided 14-16% revenue growth. Worried that there is no floor on how far the stock price can fall. Believes company will continue to grow, and has strong products.
Consumer Products

Global leader in DNA sequencing. Almost 90% recurring revenue with good growth. Highly cash generative with good balance sheet. Good acquirer. Expects DNA sequencing will be a pervasive treatment option in healthcare. (Analysts’ price target is $404.80)

Consumer Products
They're the global leader in DNA sequencing. It's had a huge run though come back a bit. It enjoys long-term technical support.
Consumer Products

(A Top Pick Sep 12/19, Up 6%) The sector is interesting, though he sold Illumina, because the holding got too big. They supply testing machines for mines, which creates recurring revenues. Stick with it.

Consumer Products
They are a provider of sequencing solutions for genetic analysis. It is a really good entry level. It is a pretty volatile stock. Commercial genetic testing is going to explode and these guys are emphasizing consumables. (Analysts’ price target is $321.79)
Consumer Products
(A Top Pick Jul 18/18, Up 15%) They analyze genetic material. We are in the early stages of doing this for a whole host of applications. They are a generation ahead of competitors. This is a technology that is still relatively new.
Consumer Products
The DNA revolution has recently started. DNA sequencing has come from the thousands of dollars to the hundreds making it ore retail. Fast growing US name. (Analysts’ price target is $345.93)
Consumer Products

He is a big believer in disrupter companies in growth sectors. This is the only company in the world that can do high volume DNA sequencing. They already have a million customers and another million order backlog. There is no one else in this space. They sell equipment and the supplies to operate the equipment. Countries will have more DNA sequencing done to help new drug development. Yield 0%. (Analysts’ price target is $286.06)

Consumer Products

Dominant player in gene sequencing business. Becoming more commercially available to clinics instead of just research labs. They are buying up some of their customers and going into competition with them. He is nervous of the valuation. It is at and beyond his expectations.

Consumer Products
Showing 1 to 11 of 11 entries
  • «
  • 1
  • »

Illumina Inc.(ILMN-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 3

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 3

Stockchase rating for Illumina Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Illumina Inc.(ILMN-Q) Frequently Asked Questions

What is Illumina Inc. stock symbol?

Illumina Inc. is a American stock, trading under the symbol ILMN-Q on the NASDAQ (ILMN). It is usually referred to as NASDAQ:ILMN or ILMN-Q

Is Illumina Inc. a buy or a sell?

In the last year, 3 stock analysts published opinions about ILMN-Q. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Illumina Inc..

Is Illumina Inc. a good investment or a top pick?

Illumina Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Illumina Inc..

Why is Illumina Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Illumina Inc. worth watching?

3 stock analysts on Stockchase covered Illumina Inc. In the last year. It is a trending stock that is worth watching.

What is Illumina Inc. stock price?

On 2022-11-25, Illumina Inc. (ILMN-Q) stock closed at a price of $218.99.